These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5489371)

  • 1. Serum creatine phosphokinase and aldolase activity in acute schizophrenic patients and their relatives.
    Meltzer HY; Grinspoon L; Shader RI
    Compr Psychiatry; 1970 Nov; 11(6):552-8. PubMed ID: 5489371
    [No Abstract]   [Full Text] [Related]  

  • 2. Creatine phosphokinase activity and clinical symptomatology. A study in acute schizophrenic patients.
    Meltzer HY
    Arch Gen Psychiatry; 1973 Nov; 29(5):589-93. PubMed ID: 4773488
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of serum CPK (creatine phosphokinase) and aldolase levels in psychiatric patients].
    Tropeano G; Del Vecchio M; Amati A; Cocorullo M; Kemali D
    Acta Neurol (Napoli); 1972; 27(4):386-94. PubMed ID: 5085163
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum creatine kinase, aldolase, and copper in acute and chronic schizophrenics.
    Coffey JW; Heath RG; Guschwan AF
    Biol Psychiatry; 1970 Oct; 2(4):331-9. PubMed ID: 5478594
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased activity of creatine phosphokinase and aldolase activity in the acute psychoses: case reports.
    Meltzer H
    J Psychiatr Res; 1970 Jul; 7(4):249-62. PubMed ID: 5477765
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the serum Levels of creatine phosphokinase and aldolase in patients with tetanus].
    Tavares W; Saddy JC; Alfradique ME; Frias LA
    Rev Inst Med Trop Sao Paulo; 1974; 16(4):189-96. PubMed ID: 4460181
    [No Abstract]   [Full Text] [Related]  

  • 7. [The value and significance of changes of serum aldolase and creatine phosphokinase in muscular diseases].
    Corridori F; Lazzaroni M; Lombardi B
    Riv Neurobiol; 1968; 14(4):573-89. PubMed ID: 5738409
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
    Ceccarelli A; Leone P
    Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscle abnormalities in acute psychoses.
    Meltzer HY; Moline R
    Arch Gen Psychiatry; 1970 Dec; 23(6):481-91. PubMed ID: 5507454
    [No Abstract]   [Full Text] [Related]  

  • 10. [Attempt at appraising the diagnostic usefulness of the determination of creatine phosphokinase, aldolase and lactic dehydrogenase activity in the serum in pediatric diseases].
    Hager-Malecka B; Drozdz M; Szczepański Z; Sobański T
    Pol Tyg Lek; 1970 Dec; 25(52):2020-2. PubMed ID: 5495539
    [No Abstract]   [Full Text] [Related]  

  • 11. [Creatine phosphokinase, transaminase and aldolase activity in rabbits poisoning with luminal].
    Kolber-Postepska B; Chibowski D; Pitera A; Szurska H
    Pol Tyg Lek; 1966 Jul; 21(30):1145-7. PubMed ID: 5981810
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum creatine phosphokinase activity in patients with trichinosis.
    Kedrowa S
    Pol Med J; 1968; 7(6):1338-43. PubMed ID: 5719282
    [No Abstract]   [Full Text] [Related]  

  • 13. Muscle enzyme release in the acute psychoses.
    Meltzer H
    Arch Gen Psychiatry; 1969 Jul; 21(1):102-12. PubMed ID: 5793673
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ergometric exercise on the activity in the serum of creatine phosphokinase, glutamate-oxaloacetate transminase and aldolase in rheumatoid arthritis.
    Kalliomäki JL; Laine VA; Ruutsalo HM
    Acta Rheumatol Scand; 1968; 14(3):185-96. PubMed ID: 5731033
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum creatine phosphokinase in muscle disease. An evaluation of two methods of determination and comparison with serum aldolase.
    Bray GM; Ferrendelli JA
    Neurology; 1968 May; 18(5):480-4. PubMed ID: 5691174
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum and cerebrospinal fluid creatine phosphokinase, aldolase and lactic dehydrogenase in cerebrovascular diseases.
    Wolintz AH; Chernik N; Christoff N; Jacobs LD; Solomon M
    Trans Am Neurol Assoc; 1968; 93():170-3. PubMed ID: 5711011
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of creatine phosphokinase, aldolase, aspartate aminotransferase and lactate dehydrogenase in the serum of hypothyroid patients].
    Pãngaro Matienzo JA
    Rev Argent Endocrinol Metab; 1968 Dec; 14(4):203-9. PubMed ID: 5760688
    [No Abstract]   [Full Text] [Related]  

  • 18. The genetic background to malignant hyperpyrexia revealed by serum creatine phosphokinase estimations in asymptomatic relatives.
    Isaacs H; Barlow MB
    Br J Anaesth; 1970 Dec; 42(12):1077-84. PubMed ID: 5504449
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of phencyclidine and stress on plasma creatine phosphokinase (CPK) and aldolase activities in man.
    Meltzer HY; Holzman PS; Hassan SZ; Guschwan A
    Psychopharmacologia; 1972; 26(1):44-53. PubMed ID: 5051461
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical, immunological and genetic studies in leprosy. I. Changes in serum lactate dehydrogenase isoenzymes, creatine phosphokinase and aldolase activity in different forms of leprosy.
    Agarwal DP; Srivastava LM; Goedde HW; Rohde R
    Tropenmed Parasitol; 1975 Jun; 26(2):207-11. PubMed ID: 1162737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.